VANGUARD GROUP INC - CYCLERION THERAPEUTICS INC ownership

CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 44 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CYCLERION THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$716,602
-33.9%
1,651,5360.0%0.00%
Q4 2022$1,083,738
-23.6%
1,651,536
+0.1%
0.00%
Q3 2022$1,419,000
+47.4%
1,650,704
-5.9%
0.00%
Q2 2022$963,000
-50.5%
1,754,1530.0%0.00%
Q1 2022$1,947,000
-39.5%
1,754,153
-6.2%
0.00%
Q4 2021$3,216,000
-26.8%
1,870,363
+30.6%
0.00%
Q3 2021$4,396,000
-20.8%
1,432,029
+0.6%
0.00%
Q2 2021$5,552,000
+19.2%
1,423,532
-14.7%
0.00%
Q1 2021$4,657,000
-8.6%
1,669,139
+0.2%
0.00%
Q4 2020$5,095,000
-51.3%
1,665,180
-3.2%
0.00%
Q3 2020$10,454,000
+57.7%
1,719,420
+53.3%
0.00%
Q2 2020$6,629,000
+93.5%
1,121,604
-13.2%
0.00%
Q1 2020$3,425,000
-2.5%
1,292,807
+0.1%
0.00%
Q4 2019$3,513,000
-77.6%
1,291,625
-0.3%
0.00%
-100.0%
Q3 2019$15,699,000
+22.4%
1,295,205
+15.6%
0.00%
Q2 2019$12,828,0001,120,3340.00%
Other shareholders
CYCLERION THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Slate Path Capital LP 7,157,601$3,105,6830.15%
Artal Group S.A. 2,779,122$1,2060.07%
MFN Partners Management, LP 3,389,215$1,470,5800.07%
Intrinsic Value Partners, LLC 43,105$18,7030.02%
COLONY GROUP LLC 102,884$440.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 115,000$49,8990.00%
Penobscot Investment Management Company, Inc. 10,000$4,3390.00%
CAPTRUST FINANCIAL ADVISORS 292,645$126,9790.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 727$3160.00%
BNP PARIBAS FINANCIAL MARKETS 91$390.00%
View complete list of CYCLERION THERAPEUTICS INC shareholders